A share price of Conmed Corp [CNMD] is currently trading at $72.88, up 2.35%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CNMD shares have gain 2.69% over the last week, with a monthly amount glided 8.21%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Conmed Corp [NYSE: CNMD] stock has seen the most recent analyst activity on February 01, 2024, when Needham reiterated its Buy rating and also boosted its price target to $129 from $119. Previously, CL King started tracking the stock with Buy rating on May 22, 2023, and set its price target to $140. On March 27, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $124 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $96 on March 21, 2023. Jefferies initiated its recommendation with a Hold and recommended $85 as its price target on October 12, 2022. In a note dated October 06, 2021, Needham upgraded an Buy rating on this stock but restated the target price of $150.
Conmed Corp experienced fluctuations in its stock price throughout the past year between $61.05 and $88.60. Currently, Wall Street analysts expect the stock to reach $97 within the next 12 months. Conmed Corp [NYSE: CNMD] shares were valued at $72.88 at the most recent close of the market. An investor can expect a potential return of 33.1% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
Trailing Twelve Months sales for Conmed Corp [NYSE:CNMD] were 1.28B which represents 4.27% growth. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.15 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.58 points at the first support level, and at 70.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.68, and for the 2nd resistance point, it is at 74.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Conmed Corp [NYSE:CNMD] is 2.27. In addition, the Quick Ratio stands at 1.06 and the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 1.75, the price to book ratio is 2.41 and price to earnings (TTM) ratio is 17.28.
Transactions by insiders
Recent insider trading involved Hartman Curt R, Officer, that happened on Nov 08 ’24 when 2849.0 shares were purchased. Officer, Peters Stanley W III completed a deal on Aug 27 ’24 to buy 2171.0 shares. Meanwhile, President AS and AET Peters Stanley W III sold 4000.0 shares on Jun 14 ’24.
